LOCATION DETERMINATION METHOD AND LOCATION DETERMINATION SYSTEM FOR SENSOR APPARATUS PLACEMENTS IN BUILDING
    111.
    发明申请
    LOCATION DETERMINATION METHOD AND LOCATION DETERMINATION SYSTEM FOR SENSOR APPARATUS PLACEMENTS IN BUILDING 审中-公开
    传感器装置位置确定方法及位置确定系统

    公开(公告)号:US20160262032A1

    公开(公告)日:2016-09-08

    申请号:US14655369

    申请日:2014-12-15

    Inventor: Jeong-Ho KIM

    Abstract: A location determining method 200 for sensor apparatus placements in building includes: a step in which a first measuring device transmits a digitally modulated first test packet through a specific channel at a first location in a building (210); a step in which a second measuring device receives the first test packet and transmits a first echo back signal through the specific channel at a second location in the building (220); a step in which the first measuring device receives the first echo back signal transmitted from the second measuring device and measures a first channel quality of the specific channel based on the first echo back signal (230); a step in which the first measuring device transmits a digitally modulated second test packet through the specific channel (240); a step in which the second measuring device receives the second test packet and transmits a second echo back signal through the specific channel (250); and a step in which the first measuring device receives the second echo back signal transmitted from the second measuring device and measures a second channel quality of the specific channel based on the second echo back signal (260).

    Abstract translation: 用于建筑物中的传感器设备布置的位置确定方法200包括:第一测量设备在建筑物(210)的第一位置通过特定通道发送数字调制的第一测试分组的步骤; 第二测量装置在建筑物(220)的第二位置处接收第一测试分组并通过特定频道发送第一回波信号的步骤; 第一测量装置接收从第二测量装置发送的第一回波信号并基于第一回波信号测量特定信道的第一信道质量的步骤; 第一测量装置通过特定频道(240)发送经数字调制的第二测试分组的步骤; 第二测量装置接收第二测试分组并通过特定频道发送第二回波信号的步骤(250); 以及第一测量装置接收从第二测量装置发送的第二回波信号并基于第二回波信号测量特定信道的第二信道质量的步骤。

    Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
    112.
    发明授权
    Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof 有权
    治疗血管疾病或KCa3.1通道介导的疾病的组合物,其包含莫达非尼或其衍生物

    公开(公告)号:US09259412B2

    公开(公告)日:2016-02-16

    申请号:US14354332

    申请日:2012-10-24

    Abstract: The present invention relates to modafinil or derivatives thereof as a medicine for the treatment of vascular diseases or KCa3.1 channel (Ca activated K channel) mediated diseases and a novel use of the same. More specifically, the present invention relates to a pharmaceutical composition for the prevention or treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or a derivative of modafinil, or pharmaceutically acceptable salts thereof which relax blood vessels and inhibit KCa3.1 channel currents by increasing intracellular cAMP, a method for treating vascular diseases or KCa3.1 channel-mediated diseases using the composition and a health functional food composition for the prevention or improvement of vascular diseases or the KCa3.1 channel-mediated diseases comprising modafinil or a modafinil derivative compound, or sitologically acceptable salts thereof.

    Abstract translation: 本发明涉及莫达非尼或其衍生物作为治疗血管疾病或KCa3.1通道(Ca激活的K通道)介导的疾病的药物及其新用途。 更具体地,本发明涉及用于预防或治疗血管疾病或KCa3.1通道介导的疾病的药物组合物,其包含莫达非尼或莫达非尼的衍生物或其药学上可接受的盐,其放松血管并抑制KCa3.1通道 通过增加细胞内cAMP,使用该组合物治疗血管疾病或KCa3.1通道介导的疾病的方法,以及用于预防或改善血管疾病或KCa3.1通道介导的疾病的健康功能食品组合物,其包含莫达非尼或 莫达非尼衍生物化合物或其可以使用的盐。

    COMPOSITION FOR DIAGNOSING OVARIAN CANCER METASTASIS USING CPG METHYLATION STATUS OF GENE PROMOTER AND USE THEREOF
    114.
    发明申请
    COMPOSITION FOR DIAGNOSING OVARIAN CANCER METASTASIS USING CPG METHYLATION STATUS OF GENE PROMOTER AND USE THEREOF 审中-公开
    使用基因启动子的CPG甲基化状态诊断卵巢癌的组合物及其用途

    公开(公告)号:US20140243218A1

    公开(公告)日:2014-08-28

    申请号:US14185099

    申请日:2014-02-20

    CPC classification number: C12Q1/6886 C12Q2600/112 C12Q2600/118 C12Q2600/154

    Abstract: The present invention relates to a composition, a kit and a method for diagnosing ovarian cancer metastasis or predicting the risk of metastasis by detecting methylation levels at CpG sites of one or more gene promoters selected from the group consisting of AGR2 (anterior gradient 2), CA9 (carbonic adj anhydrase 9), GABRP (gamma-aminobutyric acid receptor pi subunit), IFITM1 (interferon-induced transmembrane 1) and MUC13 (mucin 13).

    Abstract translation: 本发明涉及一种用于诊断卵巢癌转移或预测转移风险的组合物,试剂盒和方法,其通过检测一种或多种基因启动子的CpG位点的甲基化水平,所述基因启动子选自AGR2(前向梯度2), CA9(碳酸酐酶9),GABRP(γ-氨基丁酸受体pi亚基),IFITM1(干扰素诱导的跨膜1)和MUC13(粘蛋白13)。

    METHOD OF GENERATING ROBOT PATH AND COMPUTING DEVICE FOR PERFORMING THE METHOD

    公开(公告)号:US20250135640A1

    公开(公告)日:2025-05-01

    申请号:US18639891

    申请日:2024-04-18

    Abstract: A method of generating a robot path is provided. The method includes identifying a drawing pose set for a manipulator included in a robot in order to draw a two-dimensional (2D) image on a three-dimensional (3D) target surface, setting a profile curve by projecting surface points of the 3D target surface onto an xy-plane, determining coverage circles of the manipulator that are capable of covering all surface points of the profile curve, deriving bounding circles for a mobile platform of the robot mounting the manipulator, corresponding to each of the determined coverage circles, and generating a translation path of the robot for drawing the 2D image on the 3D target surface based on the derived bounding circles.

Patent Agency Ranking